The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ...

Chip tech provider Arm Holdings said on Wednesday it will no longer meet the top end of its previous full-year guidance, but slightly topped Wall Street's current-quarter expectations.Arm shares ...

Citi analyst Andrew Gardiner increased the price target for Arm Holdings (NASDAQ: NASDAQ:ARM) shares to $200 from the previous $170, while continuing to recommend a Buy rating for the stock. The ...

Chip-design giant Arm Holdings reported record quarterly sales on the back of a rush of artificial-intelligence chip buying but gave an outlook that disappointed investors, sending its shares down. In ...

Arm Holdings reported fiscal third-quarter results that topped Wall Street estimates and raised the midpoint of its narrowed sales outlook. ...

For the current quarter, Arm guided for adjusted per-share earnings of 48 cents to 56 cents, as well as revenue of $1.18 billion to $1.28 billion. Wall Street analysts modeled adjusted earnings of 52 ...

Arm Holdings Q3 fiscal 2025 financial results bested consensus estimates, but the Q4 outlook matched estimates, prompting ...

Chip tech provider Arm Holdings , gave a fiscal fourth-quarter forecast on Wednesday that was slightly above Wall Street's ...

Shares of several tech companies specializing in artificial intelligence products soared Wednesday after Google parent Alphabet said it plans to ramp up spending on AI.

Arm Holdings Plc has fared better than most semiconductor stocks in the days since DeepSeek sparked concerns about the outlook for spending on artificial intelligence gear — but its steep valuation ...

It may take up to two years for Motassem to undergo the corrective surgeries he needs and to be fitted for a prosthetic. (ABC ...